These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 26509444)
1. Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases. Palomo L; Xicoy B; Garcia O; Mallo M; Ademà V; Cabezón M; Arnan M; Pomares H; José Larrayoz M; José Calasanz M; Maciejewski JP; Huang D; Shih LY; Ogawa S; Cervera J; Such E; Coll R; Grau J; Solé F; Zamora L Am J Hematol; 2016 Feb; 91(2):185-92. PubMed ID: 26509444 [TBL] [Abstract][Full Text] [Related]
2. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features. Palomo L; Garcia O; Arnan M; Xicoy B; Fuster F; Cabezón M; Coll R; Ademà V; Grau J; Jiménez MJ; Pomares H; Marcé S; Mallo M; Millá F; Alonso E; Sureda A; Gallardo D; Feliu E; Ribera JM; Solé F; Zamora L Oncotarget; 2016 Aug; 7(35):57021-57035. PubMed ID: 27486981 [TBL] [Abstract][Full Text] [Related]
3. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression. Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses. Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224 [TBL] [Abstract][Full Text] [Related]
5. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome. da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923 [TBL] [Abstract][Full Text] [Related]
6. Cytogenetic risk stratification of 417 patients with chronic myelomonocytic leukemia from a single institution. Tang G; Zhang L; Fu B; Hu J; Lu X; Hu S; Patel A; Goswami M; Khoury JD; Garcia-Manero G; Medeiros LJ; Wang SA Am J Hematol; 2014 Aug; 89(8):813-8. PubMed ID: 24782398 [TBL] [Abstract][Full Text] [Related]
7. Combining metaphase cytogenetics with single nucleotide polymorphism arrays can improve the diagnostic yield and identify prognosis more precisely in myelodysplastic syndromes. Qin Y; Zhang H; Feng L; Wei H; Wu Y; Jiang C; Xu Z; Zhu H; Liu T Ann Med; 2022 Dec; 54(1):2627-2636. PubMed ID: 36148999 [TBL] [Abstract][Full Text] [Related]
8. Genome-wide high density single-nucleotide polymorphism array-based karyotyping improves detection of clonal aberrations including der(9) deletion, but does not predict treatment outcomes after imatinib therapy in chronic myeloid leukemia. Huh J; Jung CW; Kim JW; Kim HJ; Kim SH; Shin MG; Kim YK; Kim HJ; Suh JS; Moon JH; Sohn SK; Nam GH; Lee JE; Kim DH Ann Hematol; 2011 Nov; 90(11):1255-64. PubMed ID: 21384125 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic risk stratification in chronic myelomonocytic leukemia. Such E; Cervera J; Costa D; Solé F; Vallespí T; Luño E; Collado R; Calasanz MJ; Hernández-Rivas JM; Cigudosa JC; Nomdedeu B; Mallo M; Carbonell F; Bueno J; Ardanaz MT; Ramos F; Tormo M; Sancho-Tello R; del Cañizo C; Gómez V; Marco V; Xicoy B; Bonanad S; Pedro C; Bernal T; Sanz GF Haematologica; 2011 Mar; 96(3):375-83. PubMed ID: 21109693 [TBL] [Abstract][Full Text] [Related]
10. Genome-wide single-nucleotide polymorphism array-based karyotyping in myelodysplastic syndrome and chronic myelomonocytic leukemia and its impact on treatment outcomes following decitabine treatment. Yi JH; Huh J; Kim HJ; Kim SH; Kim SH; Kim KH; Do YR; Mun YC; Kim H; Kim MK; Kim HJ; Kim T; Kim DD Ann Hematol; 2013 Apr; 92(4):459-69. PubMed ID: 23262795 [TBL] [Abstract][Full Text] [Related]
11. Analyses on clinical characteristic and prognoses of 41 patients with chronic myelomonocytic leukemia in China. Chen B; Ma Y; Xu X; Wang X; Qin W; Ji M; Lin G Leuk Res; 2010 Apr; 34(4):458-62. PubMed ID: 19631982 [TBL] [Abstract][Full Text] [Related]
12. [Karyotypic analysis and prognosis for 41 patients with chronic myelomonocytic leukemia]. Lu Y; Yu MX; Mu QT; Wang Q; Chen ZM; Lou JY; Jin J Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Apr; 30(2):134-7. PubMed ID: 23568720 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma. Marescalco MS; Capizzi C; Condorelli DF; Barresi V J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501 [TBL] [Abstract][Full Text] [Related]
14. Cytogenetic risk stratification may predict allogeneic hematopoietic stem cell transplantation outcomes for chronic myelomonocytic leukemia. Motohashi K; Fujisawa S; Doki N; Kobayashi T; Mori T; Usuki K; Tanaka M; Fujiwara S; Kako S; Aoyama Y; Onoda M; Yano S; Gotoh M; Kanamori H; Takahashi S; Okamoto S; Leuk Lymphoma; 2018 Jun; 59(6):1332-1337. PubMed ID: 29032731 [TBL] [Abstract][Full Text] [Related]
15. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies. Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988 [TBL] [Abstract][Full Text] [Related]
16. Single nucleotide polymorphism array-based karyotyping shows sequential genomic changes from monosomy to copy-neutral loss of heterozygosity of chromosome 7 and 20q deletion within a balanced translocation t(14;20) in AML. Huh J; Mun YC; Seong CM; Chung WS Cancer Genet; 2011 Dec; 204(12):682-6. PubMed ID: 22285021 [TBL] [Abstract][Full Text] [Related]
17. Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Huh J; Tiu RV; Gondek LP; O'Keefe CL; Jasek M; Makishima H; Jankowska AM; Jiang Y; Verma A; Theil KS; McDevitt MA; Maciejewski JP Genes Chromosomes Cancer; 2010 Apr; 49(4):390-9. PubMed ID: 20095039 [TBL] [Abstract][Full Text] [Related]
18. Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes. Barresi V; Romano A; Musso N; Capizzi C; Consoli C; Martelli MP; Palumbo G; Di Raimondo F; Condorelli DF Genes Chromosomes Cancer; 2010 Nov; 49(11):1014-23. PubMed ID: 20725993 [TBL] [Abstract][Full Text] [Related]
19. SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3. Nowak D; Klaumuenzer M; Hanfstein B; Mossner M; Nolte F; Nowak V; Oblaender J; Hecht A; Hütter G; Ogawa S; Kohlmann A; Haferlach C; Schlegelberger B; Braess J; Seifarth W; Fabarius A; Erben P; Saussele S; Müller MC; Reiter A; Buechner T; Weiss C; Hofmann WK; Lengfelder E Genes Chromosomes Cancer; 2012 Aug; 51(8):756-67. PubMed ID: 22488577 [TBL] [Abstract][Full Text] [Related]
20. Natural history of chronic myelomonocytic leukemia treated with hypomethylating agents. Alfonso A; Montalban-Bravo G; Takahashi K; Jabbour EJ; Kadia T; Ravandi F; Cortes J; Estrov Z; Borthakur G; Pemmaraju N; Konopleva M; Bueso-Ramos C; Pierce S; Kantarjian H; Garcia-Manero G Am J Hematol; 2017 Jul; 92(7):599-606. PubMed ID: 28370097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]